Ya, that's possible. However, if we assume that the FDA will hold true to the EUA requirement "potential to help out weighs the potential risk"

Then we should get an EUA with clinical or statistical significance. If we get an EUA, we will immediately be able to provide mountains of data from the use of LL across the world.

If our reduction in our trial is as strong as I hope it is, we would be able to reduce the mortality figures enough that it would be plainly obvious to the doctors across the country that it's working.

Praying that the data is what we think, and that we are able to scale production quickly.